Shake or cookie? study tests which gluten form triggers stronger immune response in celiac patients
NCT ID NCT07039773
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how people with celiac disease react to gluten in liquid form (a shake) versus solid form (a cookie). Thirty adults on a gluten-free diet will try both, in random order, with blood samples taken to measure immune markers and symptoms. The goal is to see if liquid gluten causes a stronger immune response, which could help improve future testing methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Vital wheat gluten (gluten-containing shake and cookie)
What this could lead to
If successful, this could help researchers better understand how the form of gluten affects immune reactions in celiac disease, potentially improving future diagnostic tests.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not apply to everyone. It is designed to measure immune markers, not to test a treatment, so there is no direct benefit for participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lovisenberg Diakonale Hospital
RECRUITINGOslo, Oslo, 0456, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Oslo University Hospital
RECRUITINGOslo, Oslo, 0372, Norway
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••